La_Shipson, FG Sign Strategic Deal to Boost Local Drug and Vaccine Production

By Iyojo Ameh

In a major boost for Nigeria’s pharmaceutical sector, La_Shipson Pharmaceutical Limited has signed a strategic collaboration agreement with the Federal Government, aimed at transforming the country into a hub for world-class pharmaceutical and vaccine production.

The agreement was formalized through the Federal Ministry of Innovation, Science and Technology, and the National Biotechnology Research and Development Agency (NBRDA), a great public-private partnership to develop local drug manufacturing capacity.

Signing of the contract by both parties

Speaking at a press conference in Abuja, the Chief Executive Officer of La_Shipson Pharmaceutical Ltd., Hon. Moses Godia Shipi, described the deal as a “bold and visionary step” toward national health security.

“This partnership is a dream come true for us at La_Shipson,” said Shipi. “We have always envisioned a future where Nigerians have access to quality, affordable, and locally manufactured medicines and vaccines. Today, that vision is taking shape, thanks to the support of the Federal Government, the Ministry, and NABDA.”

The collaboration will focus on establishing scientific, infrastructural, and regulatory frameworks to support the local production of globally standardized pharmaceuticals and vaccines. Beyond reducing reliance on foreign imports, the project is also expected to spur innovation, generate employment, and improve public health outcomes nationwide.

The initiative aligns with La_Shipson’s mission to expand healthcare access and affordability for all Nigerians. With a strong emphasis on research and biotechnology, the company aims to raise standards in healthcare delivery across the African continent.

“This is more than a business move, it’s a national service,” Shipi added. “We are here to complement government efforts in achieving health security and to ensure that every Nigerian can afford the medications and vaccines they need to live a healthy life.”

Also in attendance at the press briefing were the company’s Board Chairman, Mr. Momoh Handsome Jimoh; Managing Director, Pharm. Mrs. Augusta Onah; and Pastor Favour Onyekachi, the regional overseer of Livingspring Chapel International.

The event shows La_Shipson’s commitment to innovation, integrity, and social responsibility as it embarks on this ambitious national initiative.

As La_Shipson embarks on this transformative journey, the company reiterated its commitment to innovation, integrity, and social responsibility in advancing Nigeria’s healthcare system.
“Together, we are building a healthier, self-reliant Nigeria”, he added.